Response to prasugrel and levels of circulating reticulated platelets in patients with ST-segment elevation myocardial infarction.
about
Novel hematological parameters for the evaluation of patients with myeloproliferative neoplasms: the immature platelet and reticulocyte fractions.Platelet turnover predicts outcome after coronary intervention.Drug-Free Platelets Can Act as Seeds for Aggregate Formation During Antiplatelet Therapy.Gradual increase in thrombogenicity of juvenile platelets formed upon offset of prasugrel medication.Exploring the potential of platelet proteomics in children.Platelet mean volume, distribution width, and count in type 2 diabetes, impaired fasting glucose, and metabolic syndrome: a meta-analysis.Safety of Antithrombotic Agents in Elderly Patients with Acute Coronary Syndromes.Newly Formed Reticulated Platelets Undermine Pharmacokinetically Short-Lived Antiplatelet Therapies.Impact of diabetes on immature platelets fraction and its relationship with platelet reactivity in patients receiving dual antiplatelet therapy.Update on pharmacological treatment of acute coronary syndrome without persistent ST segment elevation myocardial infarction in the elderlyImpact of immature platelets on platelet response to ticagrelor and prasugrel in patients with acute coronary syndrome.Legacy of blood: does prasugrel inhibit megakaryocytes and do juvenile platelets inherit this inhibition?Characterization of surface antigens of reticulated immature platelets.Immature platelet fraction and high-on treatment platelet reactivity with ticagrelor in patients with acute coronary syndromes.Platelet Larger Cell Ratio and High-on Treatment Platelet Reactivity During Dual Antiplatelet Therapy.Qualitative and quantitative modifications of von Willebrand factor in patients with essential thrombocythemia and controlled platelet count.Relation between ticagrelor response and levels of circulating reticulated platelets in patients with non-ST elevation acute coronary syndromes.
P2860
Q33439747-FDBAB459-8B52-4D0B-A775-0A01681AAF9AQ33721709-BA0AD1DD-3343-4F6A-A59D-F190B0530108Q36104404-100B168F-CBF8-423C-AA67-3A30E8B196ACQ36709028-45DC667F-8D46-4B2E-A49A-3B89A9952F38Q38236744-78C3D22A-1A41-43AE-8BB8-5DFA99775F58Q38271064-64ED38F7-E3C6-42EC-B31E-7F00A8DF9F91Q38760067-50426B07-FFC5-492A-9CBE-68072AF83EC9Q38916487-388CDE18-EA1E-44F2-B8FD-5202C4B7C9C8Q39941820-21B26EB2-9672-4693-8B18-1FAA11A5C6B3Q41265471-16C79CA5-92E9-4E54-BB28-72CA94FFB79EQ41541632-A624F6AA-E219-486E-876D-962028D422AFQ42943364-C7625814-D1D9-439E-A915-748300CAB346Q48276361-AA05FB0B-1C06-433A-A5FB-24A35EB95423Q48737764-B7F12501-6622-4C5B-A2D0-B535F301113FQ52912700-A20AF649-C764-430F-919F-EA6851C1B9EBQ52951456-BFE8EAAC-EFDE-4075-A200-6705424025FDQ53632893-0AFA6C95-B48D-4F9C-A86D-F299BCBBFEB8
P2860
Response to prasugrel and levels of circulating reticulated platelets in patients with ST-segment elevation myocardial infarction.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Response to prasugrel and leve ...... evation myocardial infarction.
@en
Response to prasugrel and leve ...... evation myocardial infarction.
@nl
type
label
Response to prasugrel and leve ...... evation myocardial infarction.
@en
Response to prasugrel and leve ...... evation myocardial infarction.
@nl
prefLabel
Response to prasugrel and leve ...... evation myocardial infarction.
@en
Response to prasugrel and leve ...... evation myocardial infarction.
@nl
P2093
P1476
Response to prasugrel and leve ...... evation myocardial infarction.
@en
P2093
Alexander Battler
Dorit Leshem-Lev
Eldad Rechavia
Hila Lerman-Shivek
Muthiah Vaduganathan
Noa Zemer-Wassercug
Oshrat Dadush
Pablo Codner
P304
P356
10.1016/J.JACC.2013.07.110
P407
P577
2013-10-30T00:00:00Z